GB0209507D0 - Nuclear receptor structure - Google Patents

Nuclear receptor structure

Info

Publication number
GB0209507D0
GB0209507D0 GBGB0209507.3A GB0209507A GB0209507D0 GB 0209507 D0 GB0209507 D0 GB 0209507D0 GB 0209507 A GB0209507 A GB 0209507A GB 0209507 D0 GB0209507 D0 GB 0209507D0
Authority
GB
United Kingdom
Prior art keywords
nuclear receptor
receptor structure
nuclear
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0209507.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karo Pharma AB
Abbott Laboratories
Original Assignee
Karo Bio AB
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karo Bio AB, Abbott Laboratories filed Critical Karo Bio AB
Priority to GBGB0209507.3A priority Critical patent/GB0209507D0/en
Publication of GB0209507D0 publication Critical patent/GB0209507D0/en
Priority to AU2003233315A priority patent/AU2003233315A1/en
Priority to PCT/EP2003/004900 priority patent/WO2003090666A2/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/30—Drug targeting using structural data; Docking or binding prediction
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GBGB0209507.3A 2002-04-25 2002-04-25 Nuclear receptor structure Ceased GB0209507D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0209507.3A GB0209507D0 (en) 2002-04-25 2002-04-25 Nuclear receptor structure
AU2003233315A AU2003233315A1 (en) 2002-04-25 2003-04-25 Glucocorticoid receptor protein crystals
PCT/EP2003/004900 WO2003090666A2 (en) 2002-04-25 2003-04-25 Glucocorticoid receptor protein crystals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0209507.3A GB0209507D0 (en) 2002-04-25 2002-04-25 Nuclear receptor structure

Publications (1)

Publication Number Publication Date
GB0209507D0 true GB0209507D0 (en) 2002-06-05

Family

ID=9935520

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0209507.3A Ceased GB0209507D0 (en) 2002-04-25 2002-04-25 Nuclear receptor structure

Country Status (3)

Country Link
AU (1) AU2003233315A1 (en)
GB (1) GB0209507D0 (en)
WO (1) WO2003090666A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7442554B2 (en) 2002-07-18 2008-10-28 Bristol-Myers Squibb Company Compositions and methods involving glucocorticoid receptor site II

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010042373A (en) * 1998-03-30 2001-05-25 린다 에스. 스티븐슨 Methods and compounds for modulating nuclear receptor activity
AU2818200A (en) * 1999-03-01 2000-09-21 Karo Bio Ab Homology models of the glucocorticoid receptor
WO2003015692A2 (en) * 2001-07-17 2003-02-27 Smithkline Beecham Corporation Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same

Also Published As

Publication number Publication date
WO2003090666A3 (en) 2004-01-08
AU2003233315A8 (en) 2003-11-10
WO2003090666A2 (en) 2003-11-06
AU2003233315A1 (en) 2003-11-10

Similar Documents

Publication Publication Date Title
GB2400312B (en) Back support structure
GB2393584B (en) Gas-cooled generator
GB0200476D0 (en) Reactor
GB0210809D0 (en) Reactor
GB0422928D0 (en) Foundation structure
AU2003235497A8 (en) Running-machine for wind structure
IL173337A0 (en) Receptor
GB0211904D0 (en) Nuclear transfer
EP1562980A4 (en) Nuclear factor of activated t cells receptor
AU2003233315A8 (en) Nuclear receptor structure
GB0215389D0 (en) Receptor
AU2003242852A1 (en) Nuclear hormone receptor
EP1489094A4 (en) Nuclear receptor rxr alpha isoforms
AU2003242849A8 (en) Nuclear hormone receptor
TW547546U (en) Axis structure
GB0416779D0 (en) Fixing arrangement
AU2003244831A8 (en) Human nuclear hormone receptor
PT2048159E (en) T cell receptor display
GB0321998D0 (en) Receptor
TW532712U (en) Back-cassette fixing structure
TW510387U (en) Door-in-door structure for charnel house
EP1489172A4 (en) Nuclear receptor err gamma 3
TW532412U (en) Improved structure for construction forms
TW520025U (en) Improved scale structure
GB2407108B (en) Foundation structure

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)